The story of Gilgamesh has survived 4,000 years. Now it arrives on a California opera stage, partly sung in the language it ...

Gilgamesh Pharma, a clinical-stage neuroscience company developing breakthrough therapies for psychiatric and neurological disorders, today announced the successful closing of a $60 million Series A ...

This is a visionary and essential new work, a seminal and remarkable achievement of storytelling, music, and dance.

(Reuters) -Drugmaker AbbVie is in talks to acquire privately-held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about $1 billion, Bloomberg News reported on Wednesday, ...

The Epic of Gilgamesh: It’s a tale some 4,000 years old, passed down only in an extinct writing system of wedge-shaped characters on fragments of clay tablets. And now, scholars are deciphering ...

Almost all the patients with depression who received Gilgamesh Pharmaceuticals’ psychedelic drug candidate went into remission, furthering the biotech’s attempt to follow the trail blazed by Johnson & ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. AbbVie has bought a psychedelic compound from a little ...

In last week’s column we considered the ancient Greek story of Deucalion and the wonderful ark, which saved the peoples of antiquity from a flood sent by the angry Olympian gods. We reflected on the ...

An ancient tablet containing part of the Epic of Gilgamesh that was taken from Iraq and sold to Hobby Lobby under false pretenses was returned to that country Thursday. Subscribe to read this story ad ...